-
1
-
-
85114282343
-
-
International Diabetes Federation IDF Diabetes Atlas, 7th ed.; International Diabetes Federation: Brussels, Belgium, (accessed on 25 January 2018)
-
International Diabetes Federation. International Diabetes Federation IDF Diabetes Atlas, 7th ed.; International Diabetes Federation: Brussels, Belgium, 2015; Available online: http://www.diabetesatlas.org/across-the-globe.html (accessed on 25 January 2018).
-
(2015)
-
-
-
2
-
-
85114276961
-
-
National Diabetes Statistics Report: Estimates of Diabetes and Its Burden in the United States; U.S. Department of Health and Human Services: Atlanta, GA, USA, (accessed on 25 January 2018)
-
Centers for Disease Control. National Diabetes Statistics Report: Estimates of Diabetes and Its Burden in the United States; U.S. Department of Health and Human Services: Atlanta, GA, USA, 2014. Available online: https://www.cdc.gov/diabetes/pdfs/data/statistics/national-diabetes-statistics-report.pdf (accessed on 25 January 2018).
-
(2014)
-
-
-
3
-
-
17044386953
-
Type 2 diabetes: Principles of pathogenesis and therapy
-
CrossRef
-
Stumvoll, M.; Goldstein, B.J.; van Haeften, T.W. Type 2 diabetes: Principles of pathogenesis and therapy. Lancet 2005, 365, 1333-1346. [CrossRef]
-
(2005)
Lancet
, vol.365
, pp. 1333-1346
-
-
Stumvoll, M.1
Goldstein, B.J.2
Van Haeften, T.W.3
-
4
-
-
39749147110
-
Mechanisms of disease: Molecular and metabolic mechanisms of insulin resistance and beta-cell failure in type 2 diabetes
-
CrossRefPubMed
-
Muoio, D.M.; Newgard, C.B. Mechanisms of disease: Molecular and metabolic mechanisms of insulin resistance and beta-cell failure in type 2 diabetes. Nat. Rev. Mol. Cell Biol. 2008, 9, 193-205. [CrossRef] [PubMed]
-
(2008)
Nat. Rev. Mol. Cell Biol
, vol.9
, pp. 193-205
-
-
Muoio, D.M.1
Newgard, C.B.2
-
5
-
-
73249133400
-
Epigenetics: A molecular link between environmental factors and type 2 diabetes
-
CrossRefPubMed
-
Ling, C.; Groop, L. Epigenetics: A molecular link between environmental factors and type 2 diabetes. Diabetes 2009, 58, 2718-2725. [CrossRef] [PubMed]
-
(2009)
Diabetes
, vol.58
, pp. 2718-2725
-
-
Ling, C.1
Groop, L.2
-
6
-
-
0043168215
-
Insulin secretion and insulin sensitivity pattern is different in isolated impaired glucose tolerance and impaired fasting glucose: The risk factor in Impaired Glucose Tolerance for Atherosclerosis and Diabetes study
-
CrossRefPubMed
-
Hanefeld, M.; Koehler, C.; Fuecker, K.; Henkel, E.; Schaper, F.; Temelkova-Kurktschiev, T. Insulin secretion and insulin sensitivity pattern is different in isolated impaired glucose tolerance and impaired fasting glucose: The risk factor in Impaired Glucose Tolerance for Atherosclerosis and Diabetes study. Diabetes Care 2003, 26, 868-874. [CrossRef] [PubMed]
-
(2003)
Diabetes Care
, vol.26
, pp. 868-874
-
-
Hanefeld, M.1
Koehler, C.2
Fuecker, K.3
Henkel, E.4
Schaper, F.5
Temelkova-Kurktschiev, T.6
-
7
-
-
84872158502
-
Vascular complications of diabetes: Mechanisms of injury and protective factors
-
CrossRef
-
Rask-Madsen, C.; King, G.L. Vascular complications of diabetes: Mechanisms of injury and protective factors. Cell Metab. 2013, 8, 20-33. [CrossRef]
-
(2013)
Cell Metab
, vol.8
, pp. 20-33
-
-
Rask-Madsen, C.1
King, G.L.2
-
8
-
-
33746377965
-
Contributions of beta-cell dysfunction and insulin resistance to the pathogenesis of impaired glucose tolerance and impaired fasting glucose
-
CrossRefPubMed
-
Abdul-Ghani, M.A.; Tripathy, D.; DeFronzo, R.A. Contributions of beta-cell dysfunction and insulin resistance to the pathogenesis of impaired glucose tolerance and impaired fasting glucose. Diabetes Care 2006, 29, 1130-1139. [CrossRef] [PubMed]
-
(2006)
Diabetes Care
, vol.29
, pp. 1130-1139
-
-
Abdul-Ghani, M.A.1
Tripathy, D.2
Defronzo, R.A.3
-
9
-
-
33847645068
-
Impaired fasting glucose and impaired glucose tolerance: Implications for care
-
CrossRefPubMed
-
Nathan, D.M.; Davidson, M.B.; Deftonzo, R.A.; Heine, R.J.; Henry, R.R.; Pratley, R.; Zinman, B. Impaired fasting glucose and impaired glucose tolerance: Implications for care. Diabetes Care 2007, 30, 753-759. [CrossRef] [PubMed]
-
(2007)
Diabetes Care
, vol.30
, pp. 753-759
-
-
Nathan, D.M.1
Davidson, M.B.2
Deftonzo, R.A.3
Heine, R.J.4
Henry, R.R.5
Pratley, R.6
Zinman, B.7
-
10
-
-
84862302432
-
Prediabetes: A high-risk state for developing diabetes
-
CrossRef
-
Tabak, A.G.; Herder, C.; Rathmann, W.; Brunner, E.J.; Kivimaki, M. Prediabetes: A high-risk state for developing diabetes. Lancet 2012, 16, 2279-2290. [CrossRef]
-
(2012)
Lancet
, vol.16
, pp. 2279-2290
-
-
Tabak, A.G.1
Herder, C.2
Rathmann, W.3
Brunner, E.J.4
Kivimaki, M.5
-
11
-
-
84998892200
-
Association between prediabetes and risk of cardiovascular disease and all cause mortality: Systematic review and meta-analysis
-
CrossRefPubMed
-
Huang, Y.; Cai, X.; Mai, W.; Meijun, L.; Yunzhao, H. Association between prediabetes and risk of cardiovascular disease and all cause mortality: Systematic review and meta-analysis. BMJ 2016, 355, i5953. [CrossRef] [PubMed]
-
(2016)
BMJ
, pp. 355
-
-
Huang, Y.1
Cai, X.2
Mai, W.3
Meijun, L.4
Yunzhao, H.5
-
12
-
-
0031964320
-
Screening for type 2 diabetes
-
American Diabetes Association. Screening for type 2 diabetes. Diabetes Care 1998, 21, S20-S22.
-
(1998)
Diabetes Care
, vol.21
, pp. S20-S22
-
-
-
13
-
-
0242300698
-
Follow-up report on the diagnosis of diabetes mellitus
-
Genuth, S.; Alberti, K.G.; Bennett, P.; Buse, J.; Defronzo, R.; Kahan, R.; Kitzmiller, J.; Knowler, W.C.; Lebovitz, H.; Lernmark, A.; et al. Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care 2003, 6, 3160-3167.
-
(2003)
Diabetes Care
, vol.6
, pp. 3160-3167
-
-
Genuth, S.1
Alberti, K.G.2
Bennett, P.3
Buse, J.4
Defronzo, R.5
Kahan, R.6
Kitzmiller, J.7
Knowler, W.C.8
Lebovitz, H.9
Lernmark, A.10
-
14
-
-
77954314743
-
Do people with diabetes understand their clinical marker of long-term glycemic control (HbA1c levels) and does this predict diabetes self-care behaviours and HbA1c?
-
CrossRefPubMed
-
Beard, E.; Clark, M.; Hurel, S.; Cooke, D. Do people with diabetes understand their clinical marker of long-term glycemic control (HbA1c levels) and does this predict diabetes self-care behaviours and HbA1c? Patient Educ. Couns. 2010, 80, 227-232. [CrossRef] [PubMed]
-
(2010)
Patient Educ. Couns
, vol.80
, pp. 227-232
-
-
Beard, E.1
Clark, M.2
Hurel, S.3
Cooke, D.4
-
15
-
-
84929046598
-
Prediabetes and Lifestyle Modification: Time to prevent a preventable disease
-
CrossRefPubMed
-
Tuso, P. Prediabetes and Lifestyle Modification: Time to prevent a preventable disease. Perm. J. 2014, 18, 88-93. [CrossRef] [PubMed]
-
(2014)
Perm. J
, vol.18
, pp. 88-93
-
-
Tuso, P.1
-
16
-
-
84979508881
-
Preventing diabetes: Early versus late preventive interventions
-
CrossRefPubMed
-
Tuomilehto, J.; Schwarz, P.E.H. Preventing diabetes: Early versus late preventive interventions. Diabetes Care 2016, 39, S115-S120. [CrossRef] [PubMed]
-
(2016)
Diabetes Care
, vol.39
, pp. S115-S120
-
-
Tuomilehto, J.1
Schwarz, P.E.H.2
-
17
-
-
58249088751
-
MicroRNAs: Target recognition and regulatory functions
-
CrossRefPubMed
-
Bartel, D.P. MicroRNAs: Target recognition and regulatory functions. Cell 2009, 136, 215-233. [CrossRef] [PubMed]
-
(2009)
Cell
, vol.136
, pp. 215-233
-
-
Bartel, D.P.1
-
18
-
-
33846277696
-
Repression of protein synthesis by miRNAs: How many mechanisms?
-
CrossRefPubMed
-
Pillai, R.S.; Bhattacharyya, S.N.; Filipowicz, W. Repression of protein synthesis by miRNAs: How many mechanisms? Trends Cell Biol. 2007, 17, 118-126. [CrossRef] [PubMed]
-
(2007)
Trends Cell Biol
, vol.17
, pp. 118-126
-
-
Pillai, R.S.1
Bhattacharyya, S.N.2
Filipowicz, W.3
-
19
-
-
33748928159
-
The diverse functions of microRNAs in animal development and disease
-
CrossRefPubMed
-
Kloosterman, W.P.; Plaster, R.H. The diverse functions of microRNAs in animal development and disease. Dev. Cell 2006, 11, 441-450. [CrossRef] [PubMed]
-
(2006)
Dev. Cell
, vol.11
, pp. 441-450
-
-
Kloosterman, W.P.1
Plaster, R.H.2
-
20
-
-
84906079581
-
Influence of miRNA in insulin signaling pathway and insulin resistance: Micro-molecules with a major role in type-2 diabetes
-
CrossRefPubMed
-
Chakraborty, C.; Doss, C.G.; Bandyopadhyay, S.; Agoramoorthy, G. Influence of miRNA in insulin signaling pathway and insulin resistance: Micro-molecules with a major role in type-2 diabetes. Wiley Interdiscip. Rev. RNA 2014, 5, 697-712. [CrossRef] [PubMed]
-
(2014)
Wiley Interdiscip. Rev. RNA
, vol.5
, pp. 697-712
-
-
Chakraborty, C.1
Doss, C.G.2
Bandyopadhyay, S.3
Agoramoorthy, G.4
-
21
-
-
58149473947
-
Expression of islet-specific microRNAs during human pancreatic development
-
CrossRefPubMed
-
Joglekar, M.V.; Joglekar, V.M.; Hardikar, A.A. Expression of islet-specific microRNAs during human pancreatic development. Gene Expr. Patterns 2009, 9, 109-113. [CrossRef] [PubMed]
-
(2009)
Gene Expr. Patterns
, vol.9
, pp. 109-113
-
-
Joglekar, M.V.1
Joglekar, V.M.2
Hardikar, A.A.3
-
22
-
-
9144270691
-
A pancreatic islet-specific microRNA regulates insulin secretion
-
CrossRefPubMed
-
Poy, M.N.; Eliasson, L.; Krutzfeldt, J.; Kuwajima, S.; Ma, X.; Macdonald, P.E.; Pfeffer, S.; Tuschl, T.; Rajewsky, N.; Rorsman, P.; et al. A pancreatic islet-specific microRNA regulates insulin secretion. Nature 2004, 432, 226-230. [CrossRef] [PubMed]
-
(2004)
Nature
, vol.432
, pp. 226-230
-
-
Poy, M.N.1
Eliasson, L.2
Krutzfeldt, J.3
Kuwajima, S.4
Ma, X.5
Macdonald, P.E.6
Pfeffer, S.7
Tuschl, T.8
Rajewsky, N.9
Rorsman, P.10
-
23
-
-
33748749597
-
MicroRNA-9 controls the expression of Granuphilin/Slp4 and the secretory response of insulin-producing cells
-
CrossRefPubMed
-
Plaisance, V.; Abderrahmani, A.; Perret- Menoud, V.; Jacquemin, P.; Lemaigre, F.; Regazzi, R. MicroRNA-9 controls the expression of Granuphilin/Slp4 and the secretory response of insulin-producing cells. J. Biol. Chem. 2006, 28, 26932-26942. [CrossRef] [PubMed]
-
(2006)
J. Biol. Chem
, vol.28
, pp. 26932-26942
-
-
Plaisance, V.1
Abderrahmani, A.2
Perret-Menoud, V.3
Jacquemin, P.4
Lemaigre, F.5
Regazzi, R.6
-
24
-
-
48749122914
-
Circulating microRNAs as stable blood-based markers for cancer detection
-
CrossRefPubMed
-
Mitchell, P.S.; Parkin, R.K.; Kroh, E.M.; Fritz, B.R.; Wyman, S.K.; Pogosova-Agadjanyan, E.L.; Peterson, A.; Noteboom, J.; O’Briant, K.C.; Allen, A.; et al. Circulating microRNAs as stable blood-based markers for cancer detection. Proc. Natl. Acad. Sci. USA 2008, 105, 10513-10518. [CrossRef] [PubMed]
-
(2008)
Proc. Natl. Acad. Sci. USA
, vol.105
, pp. 10513-10518
-
-
Mitchell, P.S.1
Parkin, R.K.2
Kroh, E.M.3
Fritz, B.R.4
Wyman, S.K.5
Pogosova-Agadjanyan, E.L.6
Peterson, A.7
Noteboom, J.8
O’Briant, K.C.9
Allen, A.10
-
25
-
-
79960315520
-
A specific miRNA signature in the peripheral blood of glioblastoma patients
-
CrossRefPubMed
-
Roth, P.; Wischhusen, J.; Happold, C.; Chandran, P.A.; Hofer, S.; Eisele, G.; Weller, M.; Keller, A. A specific miRNA signature in the peripheral blood of glioblastoma patients. J. Neurochem. 2011, 118, 449-457. [CrossRef] [PubMed]
-
(2011)
J. Neurochem
, vol.118
, pp. 449-457
-
-
Roth, P.1
Wischhusen, J.2
Happold, C.3
Chandran, P.A.4
Hofer, S.5
Eisele, G.6
Weller, M.7
Keller, A.8
-
26
-
-
85017487045
-
Circulating endothelium-enriched microRNA-126 as a potential biomarker for coronary artery disease in type 2 diabetes mellitus patients
-
CrossRefPubMed
-
Al-Kafaji, G.; Al-Mahroos, G.; Al-Muhtaresh, H.A.; Sabry, M.A.; Abdul Razzak, R.; Salem, A.H. Circulating endothelium-enriched microRNA-126 as a potential biomarker for coronary artery disease in type 2 diabetes mellitus patients. Biomarkers 2017, 11, 1-11. [CrossRef] [PubMed]
-
(2017)
Biomarkers
, vol.11
, pp. 1-11
-
-
Al-Kafaji, G.1
Al-Mahroos, G.2
Al-Muhtaresh, H.A.3
Sabry, M.A.4
Abdul Razzak, R.5
Salem, A.H.6
-
27
-
-
80053367552
-
Toward the blood-borne miRNome of human diseases
-
CrossRefPubMed
-
Keller, A.; Leidinger, P.; Bauer, A.; Elsharawy, A.; Haas, J.; Backes, C.; Wendschlag, A.; Giese, N.; Tjaden, C.; Ott, K.; et al. Toward the blood-borne miRNome of human diseases. Nat. Methods 2011, 8, 841-843. [CrossRef] [PubMed]
-
(2011)
Nat. Methods
, vol.8
, pp. 841-843
-
-
Keller, A.1
Leidinger, P.2
Bauer, A.3
Elsharawy, A.4
Haas, J.5
Backes, C.6
Wendschlag, A.7
Giese, N.8
Tjaden, C.9
Ott, K.10
-
28
-
-
84943635119
-
Peripheral blood microRNA-15a as a potential biomarker for type 2 diabetes mellitus and pre-diabetes
-
CrossRefPubMed
-
Al-Kafaji, G.; Al-Mahroos, G.; Alsayed, N.A.; Hasan, Z.A.; Nawaz, S.; Bakhiet, M. Peripheral blood microRNA-15a as a potential biomarker for type 2 diabetes mellitus and pre-diabetes. Mol. Med. Rep. 2015, 12, 7485-7490. [CrossRef] [PubMed]
-
(2015)
Mol. Med. Rep
, vol.12
, pp. 7485-7490
-
-
Al-Kafaji, G.1
Al-Mahroos, G.2
Alsayed, N.A.3
Hasan, Z.A.4
Nawaz, S.5
Bakhiet, M.6
-
29
-
-
84934777883
-
Identification of microRNA biomarkers in type 2 diabetes: A met-analysis of controlled profiling studies
-
CrossRefPubMed
-
Zhu, H.; Leun, S.W. Identification of microRNA biomarkers in type 2 diabetes: A met-analysis of controlled profiling studies. Diabetologia 2015, 58, 900-911. [CrossRef] [PubMed]
-
(2015)
Diabetologia
, vol.58
, pp. 900-911
-
-
Zhu, H.1
Leun, S.W.2
-
30
-
-
0031851293
-
Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: Diagnosis and classification of diabetes mellitus provisional report of a WHO consultation
-
CrossRef
-
Alberti, K.G.; Zimmet, P.Z. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: Diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet. Med. 1998, 15, 539-553. [CrossRef]
-
(1998)
Diabet. Med
, vol.15
, pp. 539-553
-
-
Alberti, K.G.1
Zimmet, P.Z.2
-
31
-
-
84954348477
-
Increased oncogenic microRNA-18a expression in peripheral blood of patients with prostate cancer: A potential role as new noninvasive biomarker
-
CrossRefPubMed
-
Al-Kafaji, G.; Al Naieb, Z.T.; Bakhiet, M. Increased oncogenic microRNA-18a expression in peripheral blood of patients with prostate cancer: A potential role as new noninvasive biomarker. Oncol. Lett. 2016, 11, 1201-1206. [CrossRef] [PubMed]
-
(2016)
Oncol. Lett.
, vol.11
, pp. 1201-1206
-
-
Al-Kafaji, G.1
Al Naieb, Z.T.2
Bakhiet, M.3
-
32
-
-
79953327099
-
Significance of serum microRNAs in pre-diabetes and newly diagnosed type 2 diabetes: A clinical study
-
CrossRefPubMed
-
Kong, L.; Zhu, J.; Han, W.; Jiang, X.; Xu, M.; Zhao, Y.; Dong, Q.; Pang, Z.; Gao, L.; Zhao, L. Significance of serum microRNAs in pre-diabetes and newly diagnosed type 2 diabetes: A clinical study. Acta Diabetolol. 2011, 48, 61-69. [CrossRef] [PubMed]
-
(2011)
Acta Diabetolol
, vol.48
, pp. 61-69
-
-
Kong, L.1
Zhu, J.2
Han, W.3
Jiang, X.4
Xu, M.5
Zhao, Y.6
Dong, Q.7
Pang, Z.8
Gao, L.9
Zhao, L.10
-
33
-
-
65249093130
-
MiR-375 maintains normal pancreatic alpha- and beta-cell mass
-
CrossRefPubMed
-
Poy, M.N.; Hausserb, J.; Trajkovskia, M.; Braunc, M.; Collinsc, S.; Rorsmanc, P.; Zavolanb, M.; Stoffela, M. miR-375 maintains normal pancreatic alpha- and beta-cell mass. PNAS 2009, 106, 5813-5818. [CrossRef] [PubMed]
-
(2009)
PNAS
, vol.106
, pp. 5813-5818
-
-
Poy, M.N.1
Hausserb, J.2
Trajkovskia, M.3
Braunc, M.4
Collinsc, S.5
Rorsmanc, P.6
Zavolanb, M.7
Stoffela, M.8
-
34
-
-
58149350343
-
MiR-375 targets 3′-phosphoinositide-dependent protein kinase-1 and regulates glucose- induced biological responses in pancreatic beta-cells
-
CrossRefPubMed
-
Ouaamari, A.E.; Baroukh, N.; Martens, G.A.; Lebrun, P.; Pipeleers, D.; Obberghen, E. miR-375 targets 3′-phosphoinositide-dependent protein kinase-1 and regulates glucose- induced biological responses in pancreatic beta-cells. Diabetes 2008, 57, 2708-2717. [CrossRef] [PubMed]
-
(2008)
Diabetes
, vol.57
, pp. 2708-2717
-
-
Ouaamari, A.E.1
Baroukh, N.2
Martens, G.A.3
Lebrun, P.4
Pipeleers, D.5
Obberghen, E.6
-
35
-
-
0035985165
-
Pancreatic beta-cell protein granuphilin binds Rab3 and Munc-18 and controls exocytosis
-
CrossRefPubMed
-
Coppola, T.; Frantz, C.; Perret-Menoud, V.; Gattesco, S.; Hirling, H.; Regazzi, R. Pancreatic beta-cell protein granuphilin binds Rab3 and Munc-18 and controls exocytosis. Mol. Biol. Cell 2002, 13, 1906-1915. [CrossRef] [PubMed]
-
(2002)
Mol. Biol. Cell
, vol.13
, pp. 1906-1915
-
-
Coppola, T.1
Frantz, C.2
Perret-Menoud, V.3
Gattesco, S.4
Hirling, H.5
Regazzi, R.6
-
36
-
-
85026135443
-
Risk factors for type 2 diabetes mellitus
-
CrossRef
-
Fletcher, B.; Gulanick, M.; Lamendola, C. Risk factors for type 2 diabetes mellitus. J. Caediovasc. Nurs. 2002, 16, 17-23. [CrossRef]
-
(2002)
J. Caediovasc. Nurs
, vol.16
, pp. 17-23
-
-
Fletcher, B.1
Gulanick, M.2
Lamendola, C.3
-
37
-
-
84896994484
-
Therapeutic interventions to reduce the risk of progression from prediabetes to type 2 diabetes mellitus
-
CrossRef
-
Portero McLellan, K.C.; Wyne, K.; Villagomez, E.T.; Hsueh, W.A. Therapeutic interventions to reduce the risk of progression from prediabetes to type 2 diabetes mellitus. Ther. Clin. Risk Manag. 2014, 20, 173-188. [CrossRef]
-
(2014)
Ther. Clin. Risk Manag
, vol.20
, pp. 173-188
-
-
Portero McLellan, K.C.1
Wyne, K.2
Villagomez, E.T.3
Hsueh, W.A.4
-
38
-
-
84872746026
-
Circulating miR-375 as a biomarker of β-cell death and diabetes in mice
-
CrossRefPubMed
-
Erener, S.; Mojibian, M.; Fox, J.K.; Denroche, H.C.; Kieffer, T.J. Circulating miR-375 as a biomarker of β-cell death and diabetes in mice. Endocrinology 2013, 154, 603-608. [CrossRef] [PubMed]
-
(2013)
Endocrinology
, vol.154
, pp. 603-608
-
-
Erener, S.1
Mojibian, M.2
Fox, J.K.3
Denroche, H.C.4
Kieffer, T.J.5
-
39
-
-
84942985712
-
MiR-375 gene dosage in pancreatic β-cells: Implications for regulation of β-cell mass and biomarker development
-
CrossRefPubMed
-
Latreille, M.; Herrmanns, K.; Renwick, N.; Tuschl, T.; Malecki, M.T.; McCarthy, M.I.; Owen, K.R.; Rülicke, T.; Stoffel, M. miR-375 gene dosage in pancreatic β-cells: Implications for regulation of β-cell mass and biomarker development. J. Mol. Med. 2015, 93, 1159-1169. [CrossRef] [PubMed]
-
(2015)
J. Mol. Med
, vol.93
, pp. 1159-1169
-
-
Latreille, M.1
Herrmanns, K.2
Renwick, N.3
Tuschl, T.4
Malecki, M.T.5
McCarthy, M.I.6
Owen, K.R.7
Rülicke, T.8
Stoffel, M.9
-
40
-
-
84923539215
-
Identification of circulating miR-101, miR-375 and miR-802 as biomarkers for type 2 diabetes
-
CrossRefPubMed
-
Higuchi, C.; Nakatsuka, A.; Eguchi, J.; Teshigawara, S.; Kanzaki, M.; Katayama, A.; Yamaguchi, S.; Takahashi, N.; Murakami, K.; Ogawa, D.; et al. Identification of circulating miR-101, miR-375 and miR-802 as biomarkers for type 2 diabetes. Metabolism 2015, 64, 489-497. [CrossRef] [PubMed]
-
(2015)
Metabolism
, vol.64
, pp. 489-497
-
-
Higuchi, C.1
Nakatsuka, A.2
Eguchi, J.3
Teshigawara, S.4
Kanzaki, M.5
Katayama, A.6
Yamaguchi, S.7
Takahashi, N.8
Murakami, K.9
Ogawa, D.10
|